Tumor site | Histology (number of cases) | Target volume | Prescribed dose, Gy | Mean PTV dose, Gy* | Coverage Index§ | Homogeneity Index§ | Irradiation time (sec) † |
---|---|---|---|---|---|---|---|
CNS (craniospinal irradiation) | Medulloblastoma (16) | Whole brain | 23,4 | 23,98 ± 0,17 | 0,78 (0,53-0,95) | 1,10 (1,07-1,21) | 912,7 (367,4 - 1991,2) |
36,0 | 36,96 ± 0,15 | 0,74 (0,47-0,90) | 1,10 (1,08-1,12) | ||||
Cribriform plate | 23,4 | 23,88 ± 0,07 | 0,86 (0,75-0,95) | 1,07 (1,04-1,09) | |||
36,0 | 36,86 ± 0,30 | 0,79 (0,62-1,00) | 1,07 (1,06-1,09) | ||||
Spinal canal | 23,4 | 23,90 ± 0,16 | 0,87 (0,73-0,91) | 1,07 (1,06-1,09) | |||
36,0 | 36,82 ± 0,45 | 0,90 (0,78-1,00) | 1,07 (1,06-1,13) | ||||
Tumor bed | 54,0 | 55,06 ± 0,49 | 0,81 (0,57-0,98) | 1,05 (1,02-1,13) | |||
CNS | Glioma (7) | Tumor/tumor bed | 45,0-59,4 | 45,18-60,76 | 0,89 (0,81-0,98) | 1,04 (1,02-1,06) | 328,0 (211,8 - 957,0) |
Abdomen | Neuroblastoma (7) | Tumor bed | 21,0 | 21,34 ± 0,13 | 0,85 (0,48-0,94) | 1,07 (1,03-1,08) | 256,8 (158,8 - 293,2) |
Thorax | Rhabdomyosarcoma (1) | Right pleura | 50,4 | 50,11 ± 0,98 | 0,84 | 1,02 | 730,3 |
PNET (Askin's tumor) (1) | Hemithorax | 14,40 | 14,83 ± 0,19 | 0,89 | 1,09 | 554,1 | |
GTV | 48,60 | 49,87 ± 0,79 | 0,74 | 1,06 | |||
Ewing sarcoma (1) | Hemithorax | 14,00 | 14,38 ± 0,24 | 0,77 | 1,07 | 519,0 | |
Tumor | 48,00 | 49,29 ± 0,22 | 0,90 | 1,08 | |||
Met L2-S1 | 48,00 | 49,22 ± 0,15 | 0,92 | 1,05 | |||
Pelvis | Rhabdomyosarcoma (1) | Inguinal nodes | 41,40 | 41,94 ± 0,59 | 0,91 | 1,05 | 327,2 |
Tumor bed | 50,40 | 51,10 ± 0,62 | 0,65 | 1,04 | |||
Total lymphatic irradiation | Hodgkin lymphoma (1) | Liver, spleen, total lymphatic | 12,00 | 12,46 ± 0,25 | 0,76 | 1,07 | 538,2 |
Total lymphatic | 21,00 | 21,74 ± 0,22 | 0,74 | 1,09 | |||
Orbit | PNET (1) | Tumor | 48,60 | 49,40 ± 0,86 | 0,55 | 1,05 | 344,1 |
Rhabdomyosarcoma (1) | Tumor bed | 50,40 | 51,93 ± 0,83 | 0,94 | 1,07 | 479,8 | |
Melanoma (1) | Tumor bed | 50,40 | 51,16 ± 0,42 | 0,98 | 1,08 | 329,6 |